Pyridine and Its Biological Activity: A Review
Prathima Patil*, S.P. Sethy, T. Sameena, K. Shailaja
Department of Medicinal Chemistry, Sushrut Institute of Pharmacy,
Tadanpally (v), Pulkal(m), Medak Dist-754202
*Corresponding Author E-mail: pratima.patil0@gmail.com
ABSTRACT:
Pyridine is a planer Six-member heterocyclic ring with 5C and 1N atom and in ring N is present in 1st and positions. The Pyridine ring is a constituent of several important natural products, including niconine, nicotine, and nucleic acid. Being a polar and ionisable aromatic compound, it improves pharmacokinetic characteristics of lead molecules and thus used as a remedy to optimize solubility and bioavailability parameters of proposed poorly soluble lead molecules. Pyridine derivatives have occupied a unique place in the field of medicinal chemistry. The incorporation of the pyridine nucleus is an important synthetic strategy in drug discovery. The high therapeutic properties of the Pyridine related drugs have encouraged the medicinal chemists to synthesize a larger number of novel chemotherapeutic agents. Pyridine drugs have broadened scope in remedying various dispositions in Clinical medicines. Numerous methods for the synthesis of Pyridine and also their various structure reactions offer enormous scope in the field of medicinal chemistry. This articles aims to review the work reported, their chemistry and biological activities of Pyridine during past years.
KEYWORDS:
INTRODUCTION:
Medicinal chemistry is the discipline concerned with determing the influence of chemical structure on biological activity and in the practice of medicinal chemistry developed from an empirical one involving organic synthesis of new compound based largely on the modification of structure and then identifies their biological activity. Medicinal chemistry concerns with the discovery, development, interpretation and the identification of mechanism of action of biologically active compounds at the molecular level. Various biologically active synthetic compounds have Six-membered nitrogen containing heterocyclic ring in their structures. Structural frameworks have been described as privileged structures and in particular, N containing polycyclic structures has been reported to be associated with a wide range of biological activity. In the field of six membered heterocyclic structures Pyridine nucleus shows various properties. The high therapeutic properties of the Pyridine related drugs have encouraged the medicinal chemists to synthesize a large number of novel chemotherapeutic agents.
Pyridine drugs have broadened scope in remedying various dispositions in clinical medicines. Medicinal properties of Pyridine include anti hypertensive, anti histaminics, anticoagulants, anti-inflammatory, antibacterial, antifungal, antiviral, ant tubercular, ant diabetic and ant malarial. Some Pyridine drugs, at high concentrations, could exert direct inhibitory action on membranes, without interference with sterols and sterol esters. Infectious microbial disease causes worldwide problem, because microbes have resisted prophylaxis or therapy longer than any other form of life. In recent decades, problems of multidrug-resistant microorganisms have reached an alarming level in many countries around the world. Resistance of anti-microbial agents such as β-lactam antibiotics, macrolides, quinolones and vancomycin etc. and different species of bacteria causes increased important global problem. Pyridine and its derivatives are reported to be physiologically and pharmacologically active and find applications in the treatment of several diseases.
Structure and pharmacological activities:
Pyridines are well known heterocyclic compounds which are common and have important feature of a variety of medicinal agents. Pyridine is a 6-membered planar ring, which is soluble in water and other polar solvents. It exists in two equivalent tautomeric forms because the hydrogen atom can be located on either of the two nitrogen atoms. It is a highly polar compound, as evidenced by a calculated dipole of 3.61D, and is entirely soluble in water. The compound is classified as aromatic due to the presence of a sextet of -electrons, consisting of a pair of electrons from the protonated nitrogen atom and one from each of the remaining four atoms of the ring. Imidazole is amphoteric, i.e. it can function as both an acid and as a base. On the basis of various literature surveys Imidazole derivatives shows various pharmacological activities
· Anti-hypertensive
· Anti-bacterial
· Anti psychotic
· Skeletal Muscle Relaxant
· Analgesic
· MAO-Inhibition
· CNS Stimulant
· Sedative
· Anti Depressant
· Anti- Cholinergic
Table: imidazole ring containing few marketed drug shows various biological activitie
STRUCTURE |
USES |
REFERENCES |
|
1.Nifedipine
dimethyl2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
It is a first generation calcium channel blocker having peripheral and coronary artery dilating properties. It is used in the treatment of angina and hypertension. |
Pandya.SN.et.al[1] |
|
2.Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
It is used as an antihypertensive in the treatment of angina pectoris |
Wang.JG.et.al[2] |
|
3.Nivaldipine
methyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
Nilvadipine is a calcium channel blocker (CCB) used for the treatment of hypertension and chronic major cerebral artery occlusion |
Pandya.SN.et..al[3] |
|
4.Sulfasalazine
2-hydroxy-5-{(Z)-[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl}benzoic acid |
It is specifically used to treat rheumatoid arthritis |
McGirt LY.et.al[4] |
|
5.Norfloxacine
4-(diethylamino)-7-fluoro-1-oxo-6-(piperazin-1-yl)-1,4-dihydronaphthalene-2-carboxylic acid |
Norfloxacin is a synthetic anti bacterial agent used for the treatment of urinary tract infection |
Rafalsky.V.et.al[5] |
|
6.Zolpidem
2-[2-(4-methylphenyl) imidazo [1,2-a]pyridin-3-yl]acetamide |
It is used for the treatment of insomnia and some brain disorders |
Lemmer B.et.al[6] |
|
7.Bromazepame
7-bromo-5-(pyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
It has mainly anxiolytic properties and at higher doses of 12 milligrams or more also shows sedative, hypnotic and skeletal muscle relaxant properties |
Guelfi JD.et.al[7] |
|
8.Flupirtine
ethyl {2-amino-6-[(4-fluorobenzyl)amino]pyridin-3-yl}carbamate |
It acts as a centrally acting non-opioid analgesic |
SwedbergMD.et.al[8] |
|
9.Harmine
1-(1-methyl-9H--carbolin-7-yl)ethanone |
It is a alkaloid having reversible MAO inhibitory properties |
Pandya.SN.et.al[9] |
|
10.Nikthimide
N,N-diethylpyridine-3-carboxamide |
It is used s a CNS stimulant and respiratory stimulant |
Martindale.et.al[10] |
|
11.Pyrilamine
N-(3-methoxybenzyl)-N',N'-dimethyl-N-(pyridin-2-yl)ethane-1,2-diamine |
It is used in over-the-counter combination products to treat the common cold and menstrual symptoms |
Parsons.et.al[11] |
|
12.Methapyriline
N,N-dimethyl-N'-(pyridin-2-yl)-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine |
it is an antihistamine and anti-cholinergic of the pyridine chemical class used for sedation |
Pandya.SN.et.al[12] |
|
13.Doxylamine
N,N-dimethyl-2-[1-(pyridin-2-yl)ethoxy]ethanamine |
It can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief |
Briggs GG.et.al[13] |
|
14. Chlorphenamine
4-(4-chlorophenyl)-N,N-dimethyl-4-(pyridin-2-yl)butan-1-amine |
Chlorphenamine is one of the most commonly used antihistamines in small-animal veterinary practice. Although not generally approved As an antidepressant or anti-anxiety medication, |
Carlsson.A.et.al[14] |
|
15.Triprolidine
2-[1-(3-chlorophenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine |
It is used to combat the symptoms associated withallergies and is sometimes combined with other cold medications designed to provide general relief for flu-like symptoms.
|
Pandya.s.n.et.al[15] |
|
16.Azatadine
6,11-Dihydro-11-(1-methyl-4-piperidine)-5H-benzo[5,6] cyclohepta[1,2,-b] pyridin |
Azatadine is an antihistamine and anticholinergic drug.
|
Zhang D.et.al[16]
|
|
17.Acrivastine
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridin-2-yl}prop-2-enoic acid |
Acrivastine is a medication used for the treatment of allergies and hay fever |
Pandya.SN.et.al[17] |
|
18.Loratidine
ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate |
Loratadine is a second-generation H1 histamine antagonist drug used to treat allergies |
Holdcroft.C.et.al[18]
|
|
19.Rocastine
2-[2-(dimethylamino)ethyl]-4-methyl-3,4-dihydropyrido[3,2-f][1,4]oxazepine-5(2H)-thione |
It is a rapid acting, non-sedating antihistamine |
Nolan JC, et.al[19]
|
|
20.Cicletamide
6-methyl-3-(4-methylphenyl)-1,3-dihydrofuro[3,4-c]pyridin-7-ol
|
H1 receptor antagonist
|
Pandya.SN.et.al[20]
|
|
21.Lupitidine
2-({2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl] ethyl} amino)-5-[(6-methylpyridin-3-yl)methyl]pyrimidin-4(3H)-one |
Lupitidine is an H2 receptor antagonist described as an antiulcer agent |
Pandya.SN.et.al[21] |
|
22.Omeprazole
1-(2-{[(4,5-dimethoxy-3-methylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazol-6-yl)ethanone |
It is a proton pump inhibitorused in the treatment of dyspepsia, peptic ulcerdisease (PUD), gastroesophageal reflux disease (GORD/GERD), laryngopharyngeal reflux (LPR) and Zollinger–Ellison syndrome. |
Ang YX.et.al[22] |
|
23.Disopyramide Phosphate
S)-4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide |
It is an ant arrhythmic medication used in the treatment of Ventricular Tachycardia |
Guyton.et.al[23] |
|
24.Nitrendipine
(RS)-ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
|
It is used in the treatment ofprimary (essential) hypertension to decrease blood pressure. |
Asif A.et.al[24] |
|
25.Felodipine
5-ethyl 3-methyl 4-(2,3- dichlorophenyl)-2-formyl-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
|
It is a drug used to control hypertension (high blood pressure) |
Pandya.SN.et.al[25] |
|
26.Lacidipine
5-diethyl 4-{2-[(1E)-3-(tert-butoxy)-3-oxoprop-1-en-1-yl]phenyl}-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
It is a calcium channel blocke |
Pandya.SN.et.al[26] |
|
27.Nicorandil
hydroxy(oxo){2-[(pyridin-4-ylcarbonyl)amino]ethoxy}ammonium |
It is a vasodilator drug used to treat angina |
Tripathi.K.D.et.al[27] |
|
28.Amrinone
5-amino-3,4'-bipyridin-6(1H)-one |
It is is a pyridine phosphodiesterase 3 inhibitor. It is a drug that may improve the prognosis in patients with congestive heart failure |
Klein N.A.et.al[28]
|
|
29.Sulmazole
2-[2-methoxy-4-(methoxysulfanyl)phenyl]-3H-imidazo[4,5-b] pyridin |
It is used In the treatment of congestive heart failure
|
Pandya.SN.et.al[29]
|
|
30.Nicotinamid
N-methylbenzamide |
It is used for type-iii hyperliporotemia |
Knip M.et.al[30] |
|
31.Pyridostigmine
1,6-dihydropyridin-3-yl dimethylcarbamate |
It is used in the treatment of myasthenia gravis |
Pandya.SN.et.al[31] |
|
32.Nicotine
3-(1-methylpyrrolidin-2-yl)pyridin |
It is use of nicotine is in treating nicotine dependence in order to eliminate smoking |
Thomas GA.et.al[32] |
|
33.Tropicamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide |
It is used in Myasthenia graves and cycloplegia
|
Manny RE.et.al[33]
|
|
34.Piperazine
11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one |
It has been used in the treatment of ulcer |
Tolerman.et.al[34]
|
|
35.Naidixic acid
1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid. |
It is used in the urinary tract infection |
Pandya.SN.et.al[35] |
|
36.Enoxacin
1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
It is used in the treatment of respiratory tract infection and urinary tract infection |
Mogabgab.WJ.et.al[36] |
|
37.Phenazopyridie HCl
3-[(Z)-phenyldiazenyl]pyridine-2,6-diamine hydrochloride |
It is used as an analgesic in urinary tat infection and dysuria |
Thomas BH.et.al[37] |
|
38. Cetylpyrdiiucloride
1-Hexadecylpyridinium chloride |
It is an antiseptic that kills bacteria and other microorganisms |
Asadoorian.et.al[38] |
|
39.Isoniazide
pyridine-4-carbohydrazide |
It is the first-line medication in prevention and treatment of tuberculosis |
Jones.et.al[39] |
|
40.Etioamide
2-ethylpyridine-4-carbothioamide |
It is an antibiotic used in the treatment of tuberculosis |
Vannelli TA.et.al [40] |
|
41.Enpirolin
(R)-(2R)-piperidin-2-yl{2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]pyridin-4-yl}methanol |
It is used as a ant malarial drugs |
Pandya.SN.et.al[41] |
|
42.Delaveridine
N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide |
It is used as part of highly active antiretroviral therapy (HAART) for the treatment of human immunodeficiency virus |
Pandya.SN.et.al[42] |
|
43.Nevirapine
11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
|
It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1infection and AIDS |
Patel SS.et.al[43] |
|
44.Indinavir
2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide |
It is a protease inhibitor used as a component of highly active antiretroviral therapy (HAART) to treat HIV infection and AIDS |
Liu, F.et.al[44] |
|
45.Dipyridodiazpine
11-cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
It is used for both IV-1 and HIV-II Infection |
Pandya, SN.et.al[45] |
|
46.Ciclopirox olamine
6-cyclohexyl-4-methylpyridin-2(1H)-one
|
It is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses |
Niewerth M.et.al[46] |
|
47.Cephapirine
3-[(acetyloxy)methyl]-8-oxo-7-{[(pyridin-4-yldisulfanyl)carbonyl]amino}-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
It is an inject able, first-generation cephalosporin antibiotic |
Pandya, SN.et.al[47] |
|
48.Iodoxyl
propyl (3,5-diiodo-4-oxopyridin-1(4H)-yl)acetate |
It is used as a diagnostic agent in kidney and uterus |
Pandya, SN.et.al[48] |
|
49.Propylidone
propyl (3,5-diiodo-4-oxopyridin-1(4H)-yl)acetate |
It is used in fistula, sinus and bronchography |
Pandya, SN.et.al[49] |
|
50.Metyrapone
2-methyl-1,2-di(pyridin-3-yl)propan-1-one |
It is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome
|
Marin.et.al[50]
|
|
51.Abiraterone
(3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol |
It is a drug used in castration-resistant prostate cancer |
O'Donnell A.et.al[51] |
|
CONCLUSON:
The reviewed pyridine moiety has shown a wide spectrum of biological activities. The various substituted pyridine and are having significant antifungal activity. Significant, antiviral and anti asthmatic activity is displayed by some effective substituted pyridine derivative which presently leading drug in the market in entire. some modified pyridine are found to to be effective as anti-hypertensive, whereas some of the derivatives of pyridine are found to show the anti-asthmatic, anti;viral as special anti HIV action. Recently it was proven that, some of the important marketed pyridine nucleous containing drug having different biological or pharmacological activity were discussed in table. The pyridine nucleolus based pharmaceutical are rapidly becoming very important class of therapeutic agents and are likely to replace many existing organic based pharmaceuticals in the very near future. The pyridine based pharmaceuticals will be produced on a large scale by modern drug Discovery Company by different research development processes and will become available commercially for therapeutic use. With the key benefits including favorable time to market and high rate of success in clinical trial compared with traditional pharmaceuticals due to diverse biological action with less toxicity, so in future therapeutic indole drug will play a pivotal role in the treatment of different diseases. The biological profiles of this new generation of pyridine represent much progress with regard to the older compounds.
REFERENCES:
1 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 400-401.
2 Wang, JG (2009). "A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention". Vascular health and risk management 5: 593–605.
3. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 43-44
4. McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA (Oct 2006). "Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine". Arch Dermatol 142 (10): 1337–1342
5 Rafalsky, V.; Andreeva, I.; Rjabkova, E.; Rafalsky, Vladimir V (2006). "Quinolones for uncomplicated acute cystitis in women". In Rafalsky, Vladimir V. Cochrane Database Syst Rev 3: CD003597. doi:10.1002/14651858.
6. Lemmer B (2007). "The sleep-wake cycle and sleeping pills".Physiol. Behav. 90 (2–3): 285–93.
7. Guelfi JD, Lancrenon S, Millet V (1993). "[Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety]".Encephale (in French) 19 (5): 547–52.
8. Swedberg MD, Shannon HE, Nickel B, Goldberg SR (September 1988). "Pharmacological mechanisms of action of flupirtine: a novel, centrally acting, nonopioid analgesic evaluated by its discriminative effects in the rat". J. Pharmacol. Exp. Ther. 246 (3): 1067–74.
9 Pandya.SN “A Test Book of Medicinal Chemistry” vol 1 page no 241-242.
10 Martindale, the Extra Pharmacopoeia, 30th ed, p1229
11 Parsons, Mike E.; Ganellin, C. Robin (January 2006). "Histamine and its receptors". British Journal of Pharmacology 147 (S1): S127–S135.
12 Pandya.SN “A Test Book of Medicinal Chemistry” vol 1 page no 321-22.
13 Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 8th edition. 2008. Published by: Lippincott Williams & Wilkins.
14 Carlsson, A.; Linqvist M. (1969). "Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines". Journal of Pharmacy and Pharmacology 21 (7): 460–464.
15. Pandya.SN “a test book of medicinal chemistry” vol 1 page no
16. Zhang D, Hansen E, Deck J, Heinze T, Sutherland J, Cerniglia C (1996). "Fungal biotransformation of the antihistamine azatadine by [[Cunninghamella elegans].".Appl Environ Microbiol 62 (9): 3477.
17. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 335-36.
18. Holdcroft, C. (1993). "Terfenadine, astemizole and loratadine: Second generation antihistamines". The Nurse practitioner 18(11): 13–14
20. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 339-40.
21 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 349-50.
22. Ang YX, Lewis JD, Epstein S, Metz DC (2006). "Long-term proton pump inhibitor therapy and risk of hip fracture". JAMA296 (24): 2947–295
23. Guyton, Arthur C., Hall, John E. (2006). Textbook of Medical Physiology (11th ed.). Philadelphia: Elsevier Saunders
24. Asif A, Siddiqui A and Polsker GL. (2004) Fixed-Dose Combination Enalapril/Nitrendipine: A Review of its use in mild-to-moderate hypertension. Drugs. 64: 1135-48
25 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 403-404.
26 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 404-405.
27. Tripathi, K.D. Essentials of Medical Pharmacology, chapter 37, page 499.
28. Klein N.A., Siskind S.J., Frishman W.H., Sonnelblick E.H., LeJemtel T.H. (1981). "Hemodynamic Comparison of Intravenous Amrinone and Dobutamine in Patients with Chronic Congestive Heart Failure". American Journal of Cardiology 48: 170–175
29 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 421-22.
30. Knip M, Douek IF, Moore WP et al. (2000). "Safety of high-dose nicotinamide: A review". Diabetologia 43 (11): 1337–45.
31. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1page no 521-522.
32. Thomas GA, Rhodes J, Green JT, Richardson C (May 2000). "Role of smoking in inflammatory bowel disease: implications for therapy". Postgrad Med J 76 (895): 273–9
33 Manny RE, Hussein M, Scheiman M, Kurtz D, Niemann K, Zinzer K (July 2001). "Tropicamide (1%): an effective cycloplegic agent for myopic children". Investigative Ophthalmology & Visual Science 42 (8): 1728–35.
34. Stolerman, Ian P. (2 August 2010).Encyclopedia of Psychopharmacology. Springer. p. 811
35. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 565-566.
36 Mogabgab, WJ. (Dec 1991). "Recent developments in the treatment of sexually transmitted diseases". Am J Med 91 (6A): 140S–144S.
37. Thomas BH, Whitehouse LW, Solomonraj G, Paul CJ (April 1990). "Excretion of phenazopyridine and its metabolites in the urine of humans, rats, mice, and guinea pigs". Journal of Pharm Sci 79 (4): 321–539
38. Asadoorian, Joanna (2008). "Cetylpyridinium chloride mouth rinse on gingivitis and plaque". Journal of Dental Hygiene.
39 Jones, David (2002). "The Health Care Experiments at Many Farms: The Navajo, Tuberculosis, and the Limits of Modern Medicine, 1952-1962". Bulletin of the History of Medicine 76 (4): 749–790.
40. Vannelli TA, Dykman A, Ortiz de Montellano PR (April 2002). "The anti-tuberculosis drug ethionamide is activated by a flavoprotein monooxygenase". J. Biol. Chem. 277 (15): 12824–9.
41. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 610-11.
42. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 713-14
43. Patel SS, Benfield P (Oct 1996). "New drug profile: nevirapine". Clinical Immunotherapeutics 6 (4): 307–317.
44 Liu, F.; Boross, P. I.; Wang, Y. F.; Tozser, J.; Louis, J. M.; Harrison, R. W.; Weber, I. T. (2005). "Kinetic, Stability, and Structural Changes in High-resolution Crystal Structures of HIV-1 Protease with Drug-resistant Mutations L24I, I50V, and G73S". Journal of Molecular Biology 354 (4): 789–800
45 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 733-34.
46 Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B. (June 2003). "Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors". Antimicrobial Agents and Chemotherapy 47 (6): 1805–17.
47. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 733-34.
48 Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 1002-3.
49. Pandya.SN “A Test Book of Medicinal Chemistry” Vol 1 page no 1002-3.
50. Marin, Marie-Frances; A. Hupbach, F. S. Maheu, K. Nader, S. J. Lupien. "Metyrapone Administration Reduces the Strength of an Emotional Memory Trace in a Long-Lasting Manner". Journal of Clinical Endocrinology & Metabolism. early release abstract (8): E1221.
51. O'Donnell A, Judson I, Dowsett M, Raynaud F, Dearnaley D, Mason M, Harland S, Robbins A, Halbert G, Nutley B, Jarman M (June 2004). "Hormonal impact of the 17alpha-hydroxylase/C (17,20)-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer". Br. J. Cancer 90 (12): 2317–25.
Received on 04.08.2013 Modified on 19.08.2013
Accepted on 23.08.2013 © AJRC All right reserved
Asian J. Research Chem. 6(10): October 2013; Page 888-899